January 19, 2012
Monsanto buys into biotech firm RaNA Therapeutics (St. Louis Business Journal)
RaNA Therapeutics raises $20.7 million to harness the potential of long non-coding RNA - Developing therapeutics using novel biology to selectively activate genes
http://www.ranarx.com/
Copyright @ 1992-2025 SeedQuest - All rights reserved
